Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$9.09 B

According to Lundbeck 's latest financial reports the company's total assets are NZ$9.09 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lundbeck - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$8.76 B3.13%
2022-12-31NZ$8.49 B10.27%
2021-12-31NZ$7.70 B-6.97%
2020-12-31NZ$8.28 B-2.3%
2019-12-31NZ$8.47 B61.33%
2018-12-31NZ$5.25 B17.15%
2017-12-31NZ$4.48 B8.56%
2016-12-31NZ$4.13 B-9.63%
2015-12-31NZ$4.57 B-14.36%
2014-12-31NZ$5.33 B0.12%
2013-12-31NZ$5.33 B14.31%
2012-12-31NZ$4.66 B1.75%
2011-12-31NZ$4.58 B9.61%
2010-12-31NZ$4.18 B-8.61%
2009-12-31NZ$4.57 B12.23%
2008-12-31NZ$4.07 B30.61%
2007-12-31NZ$3.12 B6.64%
2006-12-31NZ$2.92 B8.68%
2005-12-31NZ$2.69 B-8.26%
2004-12-31NZ$2.93 B